Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Crude Oil Moves Lower; Summit Therapeutics Shares Plummet

Author: Avi Kapoor | February 20, 2024 03:33pm

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday.

The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The S&P 500 also fell, dropping, 0.73% to 4,969.26.

Check This Out: Top 4 Tech Stocks That May Crash This Month

 

Leading and Lagging Sectors

 

Consumer staples shares rose by 1.2% on Tuesday.

In trading on Tuesday, information technology shares fell by 1.8%.

 

Top Headline

 

The Conference Board's Leading Economic Index fell 0.4% for January, versus market expectations for a 0.3% decline.

 

Equities Trading UP

 

Monopar Therapeutics Inc. (NASDAQ:MNPR) shares shot up 90% to $0.6472 after the company announced it received Human Research Ethics Committee clearance in Australia to commence a Phase 1 dosimetry trial of its novel radiopharmaceutical MNPR-101-Zr.

Shares of Biofrontera Inc. (NASDAQ:BFRI) got a boost, surging 68% to $1.25 after the company announced a private placement of up to $16 million priced at the market per Nasdaq rules. Biofrontera ALSO announced restructuring of supply agreement with Biofronter AG.

TRxADE HEALTH, Inc. (NASDAQ:MEDS) shares were also up, gaining 94% to $8.04. TRxADE HEALTH announced the sale of assets of subsidiary Trxade, Inc. to Micro Merchant Systems for $22.5 million, with potential additional $7.5 million payout.

 

Equities Trading DOWN

 

RAPT Therapeutics, Inc. (NASDAQ:RAPT) shares dropped 71% to $7.53 after the FDA verbally notified clinical hold on the company's Phase 2B trial of zelnecirnon in atopic dermatitis and Phase 2A trial in asthma.

Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) were down 28% to $3.6505 after reporting fourth-quarter results.

Fluor Corporation (NYSE:FLR) was down, falling 11% to $37.26 following fourth-quarter results.

Also Check This Out: Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday

 

Commodities

 

In commodity news, oil traded down 1.9% to $77.72 while gold traded up 0.7% at $2,039.10.

Silver traded down 1.5% to $23.12 on Tuesday while copper rose 0.6% to $3.8620.

 

Euro zone

 

European shares closed mixed today. The eurozone’s STOXX 600 fell 0.10%, London’s FTSE 100 fell 0.12% while Spain’s IBEX 35 Index rose 0.94% The German DAX fell 0.14% French CAC 40 rose 0.34% while Italy’s FTSE MIB Index rose 0.08%.

Construction output in the Eurozone increased 1.9% from the prior year in December, recording the sharpest surge since February. The current account surplus in the Eurozone rose to €42.66 billion in December compared to €16.62 billion in the year-ago period. Passenger car registrations in the European Union jumped 12.1% year-over-year to 851.7 thousand units in January.

 

Asia Pacific Markets

 

Asian markets closed mostly higher on Tuesday, with Japan’s Nikkei 225 falling 0.28%, Hong Kong’s Hang Seng Index rising 0.57%, China’s Shanghai Composite Index gaining 0.42% and India’s S&P BSE Sensex gaining 0.5%.

Hong Kong’s unemployment rate came in unchanged at 2.9% in the three months ending January.

 

Economics

 

US leading index fell 0.4% for January, versus market expectations for a 0.3% decline.

Now Read This: Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling

Posted In: BFRI FLR MEDS MNPR RAPT SMMT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist